BEAMSTART Logo

Samsung Biologics CEO focuses on global business

Korea Economic Daily LogoKorea Economic Daily1w ago

Samsung Biologics CEO focuses on global business - Korea Economic Daily

Quick Summary:

Industry sources on Wednesday said Rim decided to concurrently lead global sales operations in addition to serving as CEO, succeeding in the position James Park, a former executive at Bristol-Myers Squibb who suddenly left Samsung Biologics late last year.

The company usually employs a vice president-level executive for the job, as the first head of its CDO Development Center was Samsung Biologics Vice President Kang Ja-hoon, formerly executive director of Hanmi Pharmaceutical and the global pharmaceutical giant Novartis.

John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract development and manufacturing.


More Pictures

Samsung Biologics CEO focuses on global business - Korea Economic Daily (Picture 1)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2023-01-26 @ 10:59:00 (1 weeks ago)

News Timezone: GMT +8:00

Ranking: #1608 (out of 7874 stories this day)

News Source URL: kedglobal.com

Language: English

Article Length: 172 words

Reading Time: 1 minutes read

Sentences: 12 lines

Sentence Length: 15 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 4800534

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 7 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 22 minutes ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Samsung Biologics CEO focuses on global business" has 172 words across 12 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Which news outlet covered this story?

The story "Samsung Biologics CEO focuses on global business" was covered 1 weeks ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 7 news stories per day.

It's most recent story was published 22 minutes ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #4800534
  • URL: https://beamstart.com/news/samsung-biologics-ceo-focuses-on-16746985353026

BEAMSTART brings you the latest news, database, and jobs from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting community events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2023 BEAMSTART. All Rights Reserved.